Mingyue S. Rao
Taiping Street
Luzhou, 646000, China
Luzhou, 646000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Effect and safety of tislelizumab combined with anlotinib and radiotherapy in advanced hepatocellular carcinoma: A single-arm, single-center, phase II clinical study.
Journal: Scientific reports
Published: November 08, 2025
Survival of patients with advanced hepatocellular carcinoma based on Gustave Roussy immune score and portal vein tumor thrombosis: a single-center, retrospective, non-randomized case-controlled study.
Journal: Discover oncology
Published: April 04, 2025
Tislelizumab plus anlotinib with or without radiotherapy as first-line therapy in advanced hepatocellular carcinoma: a single center, non-randomized retrospective case-control study.
Journal: Discover oncology
Published: September 18, 2024
Construction of an interpretable model for predicting survival outcomes in patients with middle to advanced hepatocellular carcinoma (≥5 cm) using lasso-cox regression.
Journal: Frontiers in pharmacology
Published: June 20, 2024
Lasso-Cox interpretable model of AFP-negative hepatocellular carcinoma.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: May 29, 2024
Case report: A report of the complete pathological response of intrahepatic cholangiocarcinoma after conversion therapy.
Journal: Frontiers in immunology
Published: September 22, 2022
PD-1 inhibitors plus anti-angiogenic therapy with or without intensity-modulated radiotherapy for advanced hepatocellular carcinoma: A propensity score matching study.
Journal: Frontiers in immunology
Published: June 18, 2022
Heat-shock protein 90α is a potential prognostic and predictive biomarker in hepatocellular carcinoma: a large-scale and multicenter study.
Journal: Hepatology international
Published: May 08, 2022
PD-L1 expression on circulating tumor cells can be a predictive biomarker to PD-1 inhibitors combined with radiotherapy and antiangiogenic therapy in advanced hepatocellular carcinoma.
Journal: Frontiers in oncology
Published: February 11, 2022
Gamma knife radiosurgery versus transcatheter arterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: a propensity score matching study.
Journal: Hepatology international
Published: December 22, 2021
Non-Digestible Carbohydrate and the Risk of Colorectal Neoplasia: A Systematic Review.
Journal: Nutrition and cancer
Published: March 24, 2020
Advances on Cell Autophagy and Its Potential Regulatory Factors in Renal Ischemia-Reperfusion Injury.
Journal: DNA and cell biology
Published: July 27, 2019
Last Updated: 09/26/2026